ServiceNow Is Our Top Tech Compounder PickServiceNow, Inc.BATS:NOWPropNotesIn a tech world often driven by hype and speculation, ServiceNow NOW stands out as a reliable growth engine—a true compounder. Unlike flashier tech names, ServiceNow delivers steady revenue growth and expanding margins, all while offering mission-critical software to businesses. 📈 What’s a Compounder, Anyway? Compounders are companies that grow steadily over time by reinvesting profits at high returns. They may not make headlines, but they consistently outperform by: - Growing demand for their shares - Reducing share supply (or keeping dilution low) These are the businesses long-term investors love: predictable, resilient, and scalable. 🧩 Why ServiceNow Fits the Bill ServiceNow has quietly built a powerful B2B software business, helping organizations streamline operations. Here’s why it qualifies as a compounder: Strong Revenue Growth: From $3.3B in 2020 to $11.4B today Rapid Profit Growth: Net income jumped from $34M to $1.54B in the same period Operating Leverage: Margins have grown from 3.4% to 13.2%, thanks to stable 80%+ gross margins and low incremental costs Recurring subscription revenue is rising fast—up 20% YoY—driven by the mission-critical nature of its software and increasing AI capabilities. 💸 The Valuation Case Although many quant models give NOW a weak grade for valuation, context matters. Historically, the stock is trading in the middle of its typical range—about 18x sales and 58x free cash flow. Looking ahead: Analysts forecast 20% annual EPS growth through 2027 That implies a forward P/E of 42x, with potential to drop further as margins expand Combine that with AI-powered upselling and potential share buybacks, and NOW’s valuation starts to look compelling. ⚠️ Risks to Watch Premium Price Tag: If markets decline, richly valued stocks like NOW could fall harder Tough Competition: Rivals like Salesforce and Palantir are aggressively chasing similar markets ✅ Bottom Line ServiceNow may not be flashy, but its financial performance, recurring revenue model, and growth runway make it a solid long-term bet. If management reins in share dilution and continues margin expansion, this stock could deliver serious compounding over the next decade. Rating: Buy